News | September 18, 2006

Managed Ventricular Pacing at the Core of New Pacemakers

The FDA has approved Medtronic’s Adapta portfolio of fully automatic pacemakers. The system provides physiologic pacing customized to the needs of individual patients, helping to set new standards of personalized care, the company stated.

The Adapta pacemaker utilizes an exclusive pacing technology called Managed Ventricular Pacing (MVP) that delivers pacing pulses to the heart’s lower right chamber (ventricle) only when necessary, often less than two percent of the time. In addition, the Adapta pacemaker is fully automatic, meaning it continuously monitors, controls and adapts to deliver just the right level of electrical stimulation to the heart without physician interaction.

“For the first time, a pacemaker comes equipped with the combined benefits of Managed Ventricular Pacing and full automaticity,” said Dr. John Andriulli, assistant professor of medicine, director of Arrhythmia Device Program at University of Medicine and Dentistry of N.J., Cooper University Hospital. “Improved customization of pacing means greater safety and better therapy delivery for patients.”

For more information, visit www.medtronic.com.

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Sponsored Content | Videos | Pacemakers| May 23, 2017
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospita
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Sponsored Content | Videos | Pacemakers| May 16, 2017
This video, provided by Medtronic, demonstrates the implantation of Micra transcatheter pacing system (TPS).
Overlay Init